Trials / Unknown
UnknownNCT01876563
the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the comparision between the effects of vitamin D or placebo supplementation for 2 months in serum level of thioredoxin, TBP-2 and thioredoxin reductase activity in patients with type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | vitamin D | one tab 4000 IU/day vitamin D |
| DIETARY_SUPPLEMENT | placebo | one tab per day placebo |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-02-01
- Completion
- 2014-07-01
- First posted
- 2013-06-12
- Last updated
- 2013-06-12
Locations
2 sites across 1 country: Iran
Source: ClinicalTrials.gov record NCT01876563. Inclusion in this directory is not an endorsement.